Chordoma: Genetics and Contemporary Management

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Chordomas are rare, aggressive bone neoplasms arising from notochord remnants.
• Despite low-grade histology, they exhibit aggressive behavior.
• Diagnosis can be challenging due to overlapping features with other bone tumors.

Purpose of the Study:

• To provide a comprehensive overview of chordoma biology, diagnosis, and treatment.
• To highlight recent advances in understanding chordoma pathogenesis and molecular markers.
• To guide clinicians in managing chordoma patients for improved outcomes.

Main Methods:

• Review of embryological origins and molecular markers (e.g., brachyury).
• Analysis of genetic alterations and WHO classification.
• Discussion of diagnostic modalities including imaging and biopsy.
• Summary of current treatment strategies and emerging therapies.

Main Results:

• Chordoma pathogenesis involves genetic alterations in PI3K signaling and chromatin remodeling.
• WHO classification identifies distinct subtypes with prognostic implications.
• Surgery and adjuvant radiation are mainstays of treatment.
• Targeted molecular therapies show emerging promise.

Conclusions:

• Accurate diagnosis and classification are crucial for chordoma management.
• Genomic insights are improving prognostic models and therapeutic strategies.
• Multidisciplinary approaches are essential for optimizing patient outcomes in chordoma.